Intuitive Surgical, Inc. $ISRG Stock Acquired by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.1% during the third quarter, Holdings Channel.com reports. The fund owned 13,113 shares of the medical equipment provider’s stock after acquiring an additional 1,822 shares during the period. UNIVEST FINANCIAL Corp’s holdings in Intuitive Surgical were worth $5,332,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ISRG. Joel Isaacson & Co. LLC raised its position in Intuitive Surgical by 7.6% during the 3rd quarter. Joel Isaacson & Co. LLC now owns 2,853 shares of the medical equipment provider’s stock valued at $1,160,000 after purchasing an additional 201 shares during the last quarter. Jacobi Capital Management LLC increased its stake in shares of Intuitive Surgical by 52.1% during the third quarter. Jacobi Capital Management LLC now owns 2,062 shares of the medical equipment provider’s stock valued at $838,000 after buying an additional 706 shares during the period. First Command Advisory Services Inc. increased its stake in shares of Intuitive Surgical by 48.4% during the third quarter. First Command Advisory Services Inc. now owns 552 shares of the medical equipment provider’s stock valued at $224,000 after buying an additional 180 shares during the period. Riverbridge Partners LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at approximately $30,557,000. Finally, Silver Grove Financial Group Inc. raised its holdings in shares of Intuitive Surgical by 40.9% during the third quarter. Silver Grove Financial Group Inc. now owns 389 shares of the medical equipment provider’s stock valued at $158,000 after acquiring an additional 113 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, Director Gary Guthart sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the sale, the director owned 1,194,530 shares in the company, valued at $546,306,350.20. This represents a 0.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 61 shares of the firm’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the transaction, the executive vice president directly owned 581 shares of the company’s stock, valued at approximately $256,569.60. This trade represents a 9.50% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 39,056 shares of company stock worth $17,585,864. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Royal Bank Of Canada dropped their price target on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. TD Cowen reissued a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a research report on Monday, October 19th. Truist Financial decreased their price objective on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. BTIG Research reaffirmed a “buy” rating and issued a $454.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $449.53 on Thursday. The stock has a market cap of $155.83 billion, a P/E ratio of 54.36, a price-to-earnings-growth ratio of 3.10 and a beta of 1.45. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The firm has a 50-day moving average of $414.76 and a 200 day moving average of $430.83.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter last year, the firm earned $2.40 earnings per share. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. Research analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.